American Drug Delivery & Formulation Summit 2023

The American Drug Delivery & Formulation Summit 2023 is a cutting-edge conference focused on addressing the greatest challenges in pharmaceutical, biologics, and device development. This summit brings together industry experts, researchers, and innovators to share their knowledge, present new technologies, and showcase innovative solutions in drug delivery and formulation.

The event covers a wide range of topics encompassing small molecules and biologics, highlighting the latest advancements in the field. Attendees will gain insights into new technologies, innovations, and combination product concepts, along with real-world case studies.

One of the key areas of focus is enabling bioperformance prediction through data analytics. Participants will learn about the latest advancements in utilizing data analytics to improve the prediction of drug performance in biological systems, enabling more efficient drug development processes.

Another important topic is engineering prodrug therapies for infectious diseases and cancer therapy. Experts will share their research and insights on developing prodrug therapies, which are designed to be converted into their active form within the body, enhancing drug efficacy and reducing side effects.

Predictive high-throughput screening of oligonucleotide lipid nanoparticles for gene silencing will also be explored. Attendees will discover how cutting-edge screening techniques can help identify and optimize lipid nanoparticles for efficient gene silencing, enabling targeted gene therapies.

Targeted delivery of pharmacological agents in the vascular system is another area of interest. Experts will discuss the latest advancements in delivering drugs directly to the vascular system, improving treatment efficacy and reducing systemic side effects.

The evolving paradigm of post-market safety reporting for combination products will be addressed, shedding light on the challenges and opportunities in ensuring the safety of combination products, which involve the use of both pharmaceuticals and medical devices.

One of the highlights of the summit is the Port Delivery System with Ranibizumab, a novel approach to long-acting retinal drug delivery. Attendees will learn about this groundbreaking system and its potential to revolutionize the treatment of retinal diseases by providing sustained drug release.

Additionally, the event will delve into the current challenges and opportunities in developing combination products, bridging biologics delivery with medical devices. Experts will discuss strategies for successful development and regulatory considerations in this rapidly evolving field.

Lastly, the summit will explore the development of high-volume wearable drug delivery systems, which hold promise for convenient and personalized administration of medications. Attendees will gain insights into the latest advancements and future prospects in this exciting area.

Similar Events

You May Like


Mark Allen Group


Mark Allen is a trusted, family-owned media and information organisation. A continuously expanding business with circa 500 employees with the aim of connecting and educating our audiences. Mark Allen consists of MA Healthcare, MA Business, MA Agriculture, MA Education, MA Exhibitions, MA Music Leisure & Travel, MA Dentistry Media and MA Financial Media Founded in 1985, we have grown to be a global business with a diverse portfolio of market-leading brands, digital products and events providing quality content and information services to specialist business and consumer communities.

18 - 19 Sep 2023

Speakers and Delegates
Industry Experts and Thought Leaders

Usability Leader
Senior Director, Combination Product Development & Manufacturing
Associate Research Fellow, Drug Product Design
Director, SaMD and Medical Devices
Senior Vice President, Drug Delivery and Device Development
Technical Development Principal Scientist
Principal Scientist
Principal Scientist
Scientific Leader, Associate Fellow
Director Discovery Pharmaceutical Sciences
Director, Head of Formulation Development

Sponsors and Exhibitors
Brand, Media and Promotional Partners

Agilent Technologies

Analytical scientists and clinical researchers worldwide rely on Agilent to help fulfill their most complex laboratory demands.

Merck Life Science

Merck Life Sciences is a leader in biomarker immunoassays, including 200+ MILLIPLEX® multiplex kits with over 1,200 different analytes, for use with Luminex® instrumentation, an ultra-high sensitivity platform for Single Molecule Counting (SMC™), inc

Precision NanoSystems Inc.

PNI is a global leader in ushering in the next wave of genetic medicines in infectious diseases, cancer, and rare diseases.

Cambridge Consultants

Cambridge Consultants, part of Capgemini Invent, develops breakthrough products and services, creates and licenses intellectual property, and provides business consultancy in technology-critical issues for clients worldwide.

W. L. Gore & Associates

W. L. Gore & Associates is a global materials science company dedicated to transforming industries and improving lives.

STA Pharmaceutical, a WuXi AppTec Company (WuXi STA)

WuXi STA, a WuXi AppTec company, is a leading pharmaceutical development and manufacturing capability and technology platform company serving the life science industry, with four sites in China and two sites in the United States and one in Europe.


We are In it for life. With over 60 years of experience as a Contract Development and Manufacturing Organization (CDMO) we are currently a fully integrated supplier offering services for drug substance, drug product intermediate and drug product.


Gerresheimer is the global partner for pharma, biotech, healthcare and cosmetics with a very broad product range for pharmaceutical and cosmetic packaging and drug delivery devices.

Quotient Sciences

Quotient Sciences is a drug development and manufacturing accelerator providing integrated programs and tailored services across the entire development pathway.

Pfanstiehl, Inc.

Founded in 1919 by Carl A. Pfanstiehl, our company specializes in isolation, purification, custom synthesis and scale-up development of cGMP, high purity and low endotoxin (HPLE) Injectable Formulation Components, Pharmaceutical Intermediates and Act


Nanoform is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners globally to provide hope for patients in developing new and improved medicines utilizing Nanoform’s platform technologies.


MUNIT is a new and innovative consultancy company, operating in the field of #MICRONIZATION of Active Pharmaceutical Ingredients (APIs), High Potent APIs, Cytotoxic and Cytostatic compounds, Inhalation products, Steroids, R&D compounds and Generics.

The Lubrizol Corporation

The Lubrizol Corporation, a Berkshire Hathaway company, is committed to enabling a sustainable future.


At Lonza, we enable #AHealthierWorld by supporting our healthcare customers on the path to commercialization.


Ardena is a pharmaceutical CDMO that guides companies through the drug discovery and development process to help create effective and compliant drug substance and products for clinical trials.


Celanese is a global technology leader in the production of differentiated chemistry solutions and specialty materials used in most major industries and consumer applications.

Sever Pharma Solutions

Sever Pharma Solutions brings your pharmaceutical ideas to life by offering expertise in high potent drug development, a drive to enhance performance, a passion for perfection, and a commitment to be your partner through the whole journey.

Oakwood Labs

Oakwood Labs offers a one-stop shop to support all phases of long acting injectable (LAI) development ranging from initial feasibility through commercial supply.


Yirdoc is a leading provider of customized mesh nebulizers for inhalation delivery needs. Our mesh nebulization technology and digital platform are designed to facilitate formulation development and improve clinical results by increasing the total do

Croda Pharma

Croda Pharma is a leading partner for the development of excipients and the supply of high purity materials for pharmaceutical formulations. The company is focused on empowering drug delivery, through its adjuvant systems, small molecule, protein, an

Captisol, a Ligand technology

Captisol® is a patent protected, uniquely modified cyclodextrin, whose chemical structure was rationally designed to maximize safety and optimize interaction to improve the solubility, stability, bioavailability or lessen volatility, irritation, smel


Get emails from us

Thank you
Oops! Something went wrong